CD Genomics is providing a novel, flexible, and scalable genome-wide DNA methylation profiling method, MethylRAD, to allow for de novo methylation analysis with extremely low DNA input.
The Introduction of MethylRAD-Seq
MethylRAD uses methylated modified dependent endonuclease, such as FspEI, MspJI, LpnPI, AspBHI, etc., to recognize cytosine methylated on DNA and cut double chains at a distance downstream of the recognition site, and if the DNA double-strand has a central symmetric methylation state, a fixed length of double-strand DNA fragment can be cut and then sequenced. DNA methylation is a heritable epigenetic mark and plays a vital role in many biological processes such as embryogenesis, cellular differentiation, X-chromosome inactivation, genomic imprinting and transposon silencing, perturbed methylation patterns are sometimes a hallmark of important human diseases. Profiling the DNA methylation landscape and its dynamics enable researchers to look deeply into key epigenetic mechanisms that modulate development and diseases. MethylRAD allows for de novo (reference-free) methylation analysis, extremely low DNA input (e.g. 200 ng) and adjustment of tag density, all of which are still unattainable for most widely used methylation profiling methods such as RRBS and MeDIP sequencing.
Key Features and Advantages of MethylRAD-Seq
- Extremely low amount of input DNA required
- Adjustable tags density
- High specificity, sensitivity and reproducibility
- Allows for de novo methylation analysis
- Ideally suited for large-scale methylation profiling
- Comprehensive bioinformatics analysis
- Suitable for most species especially plant species
The MethylRAD-Seq Workflow is outlined as below:
|Sample requirements and preparation
- The original sequencing data
- Experimental results
- Data analysis report
- Details in MethylRAD for your writing (customization)
CD Genomics uses a simple and flexible method for genome-wide DNA methylation profiling with high specificity, sensitivity and reproducibility, enabling de novo methylation analysis with extremely low DNA input, and flexible adjustment of tag density. If you have any questions, please feel free to contact us.
1. What about the unique mapping ratios?
Of the mapped reads provided by MethylRAD, the unique mapping ratios were 34.5%~36.1%, which comparable to those (38–43%) reported in a WGBS study on A. thaliana, and the relatively low rate of unique mapping is to be expected as repetitive regions are usually highly methylated in plants.
2. How sensitive MethylRAD-seq can be?
At methylation levels of 20-100%, CCGG and CCWGG sites could be readily detected and the detection rates were 93.8-100%. While lower detection rates were seen at the low methylation level (less than 20%), more than 79% of the CCGG and CCWGG sites could still be detected.
An exemplary chromosomal distribution of (a) methylated CCGG sites and (b) methylated CCWGG sites detected by MethylRAD, RTR-MethylRAD and WGBS:
A large majority of methylated target sites detected by WGBS are also detected by MethylRAD.
3. Theoretically, MethylRAD sequences methylated fragments only, how to eliminate false positives detected?
For plant applications, it is advisable to use the chloroplast sites as internal control sites to adjust the false discovery rate of detected methylation sites to the desired level.
Scanning indels in the 5q22.1 region and identification of the TMEM232 susceptibility gene that is associated with atopic dermatitis in the Chinese Han population
Published: 25 March 2017
Atopic dermatitis (AD) is a chronic inflammatory skin disease. The 5q22.1 regionwas found to have an association with AD in our previous genome-wide association study (GWAS).
The genotyping and association analysis showed that six deletions and four SNPs were associated with AD (P < 0.005). The rs11357450 (Pcombined = 7.79E-04, OR = 1.39, logBayes Factor = 1.29) deletion located in TMEM232 was identified to be the strongest variant. Analysis of the genetic model revealed that the dominant model best described rs11357450 (P = 1.96E-03, OR=1.22; 95% CI=1.07-1.37). IHC showed that the expression of TMEM232 decreased gradually from the granular layer to the basal layer in AD, but in normal tissues, this trend was reversed. Additionally, positive cytoplasm staining was found in lymphocytes around the blood vessels in AD.
Table.1 Sample summary information in the replication studies.
Fig.1 The LDmap among 10 variants genotyped in validation population. Rs11357450was in strong LD with other two significant variants, all pairwise r2 > 0.82 in validation sample set. Numbers inside the squares represent D’.
Fig.2 The results of stepwise logistic regression and the gene location of variants. The associations at the other five deletions and four SNPs disappeared (the smallest P = 0.33) after the genetic effect of the SNP (rs11357450) was controlled in the locus, which showed that rs11357450 was strong signal in this region.
Table.2 Association evidence for ten loci in validation and combined studies of Chinese Han.
A1/A2, Minor allele/Major allele; MAF, Minor allele frequencies; OR, odds ratio; CI, confidence interval; BF: Bayes factor.
In Conclusion, the study indicates that TMEM232 in the 5q22.1 region is the causal gene for AD in the Chinese Han population.
Wu Y Y, et al. Scanning indels in the 5q22.1 region and identification of the TMEM232 susceptibility gene that is associated with atopic dermatitis in the Chinese Han population. Gene, 2017, 617:17-23.